In the dynamic fields of oncology and haematology, reliable and advanced cellular therapies are essential to enhancing patient outcomes. Biovault is a bioresource for NHS and private consultants, providing trusted and proven cellular processing, storage, and distribution. Our expertise spans from initial research support to full-scale production, making us a dependable long-term partner.
Comprehensive Cellular Processing Services
Biovault specialises in the processing, storage, and distribution of cellular products and human tissues for both clinical and research purposes. Operating from a fully accredited facility, our services are designed to meet the highest industry standards. Key features include:
Regulatory Compliance: We process minimally manipulated products for human application, adhering to standards set by the Human Tissue Authority (HTA), JACIE and Good Distribution Practice (GDP), as well as the requirements of our MHRA WDA(H) licence.
End-to-End Solutions: From initial processing to secure storage and efficient distribution, we ensure a seamless service designed to support your clinical needs.
Our Cellular Products and Therapies
Biovault processes, stores, and distributes a diverse range of cellular products, each tailored to support cutting-edge therapies:
Haematopoietic Progenitor Cells (HPCs)
HPC (A): Apheresis-derived peripheral blood stem cells (PBSCs).
HPC (M): Marrow-derived stem cells.
HPC (CB): Cord blood-derived stem cells.
Cellular Therapies & T-Cell Products
TC-T Therapies & CAR-T Cell Therapies: Pioneering solutions in immunotherapy to support targeted treatments.
Donor Lymphocyte Infusion (DLI): Enhancing cellular therapy applications to improve patient outcomes.
Immune Effector Cells (IECs): Available under our MHRA WDA(H) licence terms, ensuring safe and effective storage and distribution.
Supporting Research and Healthcare Organisations
At Biovault, we understand the importance of collaboration in driving innovation in cellular therapies. We work closely with Contract Research Organisations (CROs), the NHS, and research laboratories, offering tailored solutions such as:
CRO Outsourcing: Expertise in blood fractionation for both clinical and research applications.
Advanced Assays: Including Flow Cytometry and CFU (Colony Forming Unit) assays for precise cell characterisation and quality assessment.
Cell Culture and Expansion: Providing high-quality cell culture services essential for research and clinical scale-up.
Processing and Storage of HSCs: Expert preparation and cryopreservation of haematopoietic stem cells to ensure integrity and viability.
Why partner with Biovault?
Biovault is trusted by global organisations, the NHS, and laboratories for our high-quality, integrated services. Our proven track record is built on:
Accredited Facilities: Our highly regulated facility ensures adherence to the highest quality standards.
Extensive Expertise: Decades of experience in cellular and tissue therapies.
Integrated Solutions: Comprehensive services covering processing, storage, and distribution.
Support for Innovation: Collaborative partnerships that drive advancements in cellular therapies.
Reliability: A dependable bioresource, trusted to support the demanding needs of oncologists and haematologists.